- Blood Sugar
- Clinical Studies
- Complementary Medicine
- Diabetes and Men
- Erectile Dysfunction
- Food and Nutrition
- Insulin Pumps
- Meters and Test Strips
- Product Recalls
- Type 1
- Type 2
- Weight Loss Surgery
Sitting Less and Moving More Could Reduce Risk of Type 2 Diabetes
March 2, 2013 (University of Leicester) — New research led at the University of Leicester reveals that individuals at high risk of developing type 2 diabetes would benefit from being told to sit less and move around more often- rather than simply exercising regularly. The experts suggest that reducing sitting time by 90 minutes in total per day could lead to important health benefits.
Currently, at risk patients are advised to engage in moderate-to-vigorous physical activity (MVPA) for at least 150 mins per week. But the new study published in Diabetologia (The journal of the European Association for the Study of Diabetes) suggests that patents should in fact be advised to reduce their sedentary time (time spent moving very little or not at all, for example sitting or lying down).The research was led by Joseph Henson and colleagues from the Diabetes Research Unit, University of Leicester and National Institute for Health Research (NIHR) Leicester Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit (BRU), UK.
Henson and colleagues analysed patients from two studies: 153 from project STAND (Sedentary Time and Diabetes study, mean age 33 years, 29% men) and the Walking Away from Diabetes study (mean age 64 years, 65% men). The team examined the extent to which sedentary time, breaks in sedentary time, MVPA and total physical activity were independently associated with cardiometabolic risk factors in a population with known risk factors for type 2 diabetes. Accelerometers were used to assess sedentary time, MVPA, and total physical activity. Breaks in sedentary time were defined as a transition from a sedentary to an active state.
The researchers found that for these patients with known risk factors for type 2 diabetes recruited from primary care, sedentary time was detrimentally associated with 2 h glucose, triacylglycerol and HDL-cholesterol, independent of measured confounders. These results remained significant after further adjustment for MVPA and adiposity.
Furthermore, the findings were consistent across groups with diverse age ranges, providing evidence that the negative consequences of excess sedentary time exist across young to old adults. Interestingly, sedentary time was shown to have stronger associations with several important cardiometabolic markers (2 h glucose, triacylglycerol and HDL-cholesterol) compared with total physical activity and MVPA, after adjustment for each other and other important confounders.
"These studies provide preliminary evidence that sedentary behaviour may be a more effective way to target the prevention of type 2 diabetes, rather than just solely focusing on MVPA. Moreover, sedentary time occupies large portions of the day, unlike MVPA," says Henson.
He adds that the new data raise questions regarding the possible prescription of optimal daily movement for health. He concludes: "Diabetes and cardiovascular prevention programmes concentrating solely on MVPA may overlook an area that is of fundamental importance to cardiometabolic health. Along with messages related to accumulating at least 150 min/week of MVPA, which form the cornerstone of diabetes prevention programmes, such interventions may be more effective still if individuals are further encouraged to simply sit less and move more, regardless of the intensity level."
He concludes: "This approach requires a paradigm shift, so that individuals at high risk of developing type 2 diabetes think about the balance of sedentary behaviour and physical activity throughout the day."
Mr Joseph Henson, Department of Cardiovascular Sciences, University of Leicester, Leicester Diabetes Centre and NIHR Leicester Loughborough Diet, Lifestyle and Physical Activity BRU, UK. T) +44 116 258 4436 E) email@example.com
Alternative contact for Mr Henson: Ather Mirza, Director of Press and Corporate News, University of Leicester, UK T) +44 116 252 3335 E) firstname.lastname@example.org
Tony Kirby of Tony Kirby PR Ltd, Currently in Australia, please contact via email. (Back in UK on Thursday 28 Feb, travelling throughout Wednesday 27 Feb) E) email@example.com
For a copy of the embargoed paper, see: http://www.diabetologia-journal.org/files/Henson.pdf (note this link is for journalists only and is hidden from the general public until the embargo lifts. Once the embargo lifts, you may include this link in your story)
Notes to editors: The research was supported by the NIHR Leicester-Loughborough Diet Lifestyle and Physical Activity BRU based at the University Hospitals of Leicester, University of Leicester and Loughborough University and the NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) based at the University of Leicester. Project STAND was funded by the Medical Research Council and National Prevention Research Initiative funding partners.
This article presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.
The National Institute for Health Research (NIHR) is funded by the Department of Health to improve the health and wealth of the nation through research. Since its establishment in April 2006, the NIHR has transformed research in the NHS. It has increased the volume of applied health research for the benefit of patients and the public, driven faster translation of basic science discoveries into tangible benefits for patients and the economy, and developed and supported the people who conduct and contribute to applied health research. The NIHR plays a key role in the Government's strategy for economic growth, attracting investment by the life-sciences industries through its world-class infrastructure for health research. Together, the NIHR people, programmes, centres of excellence and systems represent the most integrated health research system in the world. For further information, visit the NIHR website (www.nihr.ac.uk).
The National Prevention Research Initiative (NPRI) is a national initiative made up of government departments, research councils and major medical charities that are working together to encourage and support research into chronic disease prevention. The initiative is co-ordinated by the Medical Research Council. www.mrc.ac.uk/npri
One in Ten AMI Patients Have Unrecognized Incident Diabetes
Two New LDL Cholesterol Drugs May Have Big Impact on Heart Disease
COBA Conference Steers Forward in the Fight Against Childhood Obesity
Google Secures Patent for Glucose-Sensing Contact Lens
Medtronic to Use GlucoSitter Artificial Pancreas Software in Future Insulin Pumps - A Big Deal!